176 327

Full metadata record

DC FieldValueLanguage
dc.contributor.author박선철-
dc.date.accessioned2021-03-24T07:00:44Z-
dc.date.available2021-03-24T07:00:44Z-
dc.date.issued2019-12-
dc.identifier.citationPSYCHIATRY AND CLINICAL PSYCHOPHARMACOLOGY, v. 29, no. 4, page. 895-898en_US
dc.identifier.issn2475-0573-
dc.identifier.issn2475-0581-
dc.identifier.urihttps://www.tandfonline.com/doi/full/10.1080/24750573.2019.1695994-
dc.identifier.urihttps://repository.hanyang.ac.kr/handle/20.500.11754/160841-
dc.description.abstractObjective: Using data from the Research on Asian Psychotropic Prescription Patterns for Antipsychotics (REAP-AP), our study aimed to establish the remission and severity ranges (mild, moderate, and severe) of schizophrenia on the Brief Psychiatric Rating Scale-6 (BPRS-6). Methods: A total of 1,438 patients with schizophrenia from India, Indonesia, Japan, Malaysia, and Taiwan were enrolled in the study. Using the receiver operating characteristic (ROC) curve analyses, the optimal cut-off scores for the remission and severity ranges on the BPRS-6 were established. Results: The scalability of the BPRS-6 was considered to have an acceptable "unidimensionality" (coefficient of scalability = 0.43). The cut-off scores for the remission of schizophrenia and mild, moderate, and severe schizophrenia can be optimally defined as the BPRS-6 total score of <5, 5-9, 10-19 and >20, respectively. Conclusion: The BPRS-6 can be a promising, brief, and unidimensional rating scale to supplement the measurement-based care of schizophrenia.en_US
dc.description.sponsorshipThis work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT) (2019R1A2C1090146).en_US
dc.language.isoenen_US
dc.publisherTAYLOR & FRANCIS LTDen_US
dc.subjectBrief Psychiatric Rating scale-6 (BPRS-6)en_US
dc.subjectseverity rangesen_US
dc.subjectschizophreniaen_US
dc.subjectunidimensionalityen_US
dc.subjectcut-off scoreen_US
dc.titleEstablishing the Cut-off Scores for the Severity Ranges of Schizophrenia on the BPRS-6 Scale: Findings from the REAP-APen_US
dc.typeArticleen_US
dc.identifier.doi10.1080/24750573.2019.1695994-
dc.relation.journalPSYCHIATRY AND CLINICAL PSYCHOPHARMACOLOGY-
dc.contributor.googleauthorPark, Seon-Cheol-
dc.contributor.googleauthorJang, Eun Young-
dc.contributor.googleauthorKim, Kiwon-
dc.contributor.googleauthorLee, Hoseon-
dc.contributor.googleauthorChoi, Joonho-
dc.contributor.googleauthorDan, Amitava-
dc.contributor.googleauthorHussain, Arshad-
dc.contributor.googleauthorTanra, Andi Jayalangkara-
dc.contributor.googleauthorKato, Takahiro A.-
dc.contributor.googleauthorChee, Kok Yoon-
dc.relation.code2019042345-
dc.sector.campusS-
dc.sector.daehakCOLLEGE OF MEDICINE[S]-
dc.sector.departmentDEPARTMENT OF MEDICINE-
dc.identifier.pidpsc76-
dc.identifier.researcherIDAAP-1575-2020-
dc.identifier.orcidhttp://orcid.org/0000-0003-3691-4624-


qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE